|
August 6, 2024
Abrysvo, the Pfizer RSV vaccine that is approved for pregnant people is now available to order. Pregnant people who are eligible for MnVFC (MA, uninsured, underinsured at some sites) can get MnVFC RSV vaccine.
Abrysvo should be given to pregnant people at 32 to 36 weeks gestation from September through January to help protect the newborn infant from RSV. Babies born at least 2 weeks after vaccination should not receive the monoclonal antibody Beyfortus, Nirsevimab, except in rare circumstances.
Abrysvo has been added to the MnVFC order form. It is available in individual single dose vials. Please consider your patient population when placing orders.
For sites that have multiple RSV products, make sure to educate staff on the different uses and indications to avoid vaccination errors. Just a reminder that Arexvy (GSK) is not approved for pregnant people.
|
